Federated Hermes
TECX

Federated Hermes’s Tectonic Therapeutic TECX Stock Holding History

Federated Hermes’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-126
Closed -$1.51K – 2239
2023
Q1 		$1.51K Sell
126
-472
-79% -$6.57K ﹤0.01% 2020
2022
Q4 		$5.12K Sell
598
-197
-25% -$1.73K ﹤0.01% 1926
2022
Q3 		$6K Buy
795
+14
+2% +$155 ﹤0.01% 1880
2022
Q2 		$9K Sell
781
-203,304
-100% -$2.4M ﹤0.01% 1844
2022
Q1 		$3.23M Sell
204,085
-12,203
-6% -$252K 0.01% 890
2021
Q4 		$9.99M Buy
216,288
+17,256
+9% +$991K 0.02% 645
2021
Q3 		$13.3M Sell
199,032
-3,047
-2% -$250K 0.03% 572
2021
Q2 		$21.6M Buy
202,079
+12,015
+6% +$1.42M 0.04% 460
2021
Q1 		$28.9M Buy
190,064
+85,647
+82% +$13.9M 0.06% 398
2020
Q4 		$17.5M Buy
104,417
+46,990
+82% +$8.35M 0.04% 505
2020
Q3 		$8.97M Buy
57,427
+33,494
+140% +$6.75M 0.02% 592
2020
Q2 		$5.01M Buy
+23,933
New +$4.93M 0.01% 713
2020
Q1 		– Sell
-156
Closed -$38K – 2371
2019
Q4 		$38K Buy
156
+149
+2,129% +$28.7K ﹤0.01% 1768
2019
Q3 		$1K Buy
+7
New +$1.58K ﹤0.01% 2140
2019
Q1 		– Sell
-8
Closed -$2K – 2241
2018
Q4 		$2K Buy
+8
New +$2.44K ﹤0.01% 2093

Other funds holding TECX

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Federated Hermes's TECX Position: Q2 2023 in Review

Federated Hermes sold out of Tectonic Therapeutic (TECX) in Q2 2023, closing a stake of 126 shares — an estimated $1.51K sold.

Federated Hermes first reported a position in TECX in Q4 2018 and held it in 15 quarters. The position peaked at $28.9M in Q1 2021. 40 funds tracked by Wall St. Rank hold TECX as of Q2 2023.

  • Federated Hermes reported no remaining Tectonic Therapeutic position as of Q2 2023 after selling out during the quarter.
  • Federated Hermes sold 126 Tectonic Therapeutic shares in Q2 2023, an estimated $1.51K.
  • Federated Hermes first reported a position in Tectonic Therapeutic in Q4 2018 and held it in 15 quarters.
  • Federated Hermes's Tectonic Therapeutic position peaked at $28.9M in Q1 2021.
  • 40 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2023.

Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.